Cargando…

Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF

BACKGROUND: To report on relationships among baseline serum anti-Müllerian hormone (AMH) measurements, blastocyst development and other selected embryology parameters observed in non-donor oocyte IVF cycles. METHODS: Pre-treatment AMH was measured in patients undergoing IVF (n = 79) and retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sills, E Scott, Collins, Gary S, Brady, Adam C, Walsh, David J, Marron, Kevin D, Peck, Alison C, Walsh, Anthony PH, Salem, Rifaat D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241207/ https://www.ncbi.nlm.nih.gov/pubmed/22136508 http://dx.doi.org/10.1186/1477-7827-9-153

Ejemplares similares

Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study
por: Yang, Zhihong, et al.
Publicado: (2012)

Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients
por: Sills, E Scott, et al.
Publicado: (2012)

Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment
por: Sadruddin, Sheela, et al.
Publicado: (2020)

Recipient screening in IVF: First data from women undergoing anonymous oocyte donation in Dublin
por: Walsh, Anthony PH, et al.
Publicado: (2011)

Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation
por: Liu, Jiaen, et al.
Publicado: (2012)

IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister
por: Sills, Eric Scott, et al.
Publicado: (2010)

Ovarian serous adenocarcinoma identified during IVF: diagnostic approach, surgical management, and reproductive outcome
por: Walsh, David J, et al.
Publicado: (2009)

First Irish delivery following sequential, two-stage embryo and blastocyst transfer
por: Hayrinen, L. H., et al.
Publicado: (2009)

Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes
por: Choi, Min Hye, et al.
Publicado: (2011)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles
por: Wu, Cheng-Hsuan, et al.
Publicado: (2019)

IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels
por: Zhang, Bingqian, et al.
Publicado: (2019)

Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
por: Scheffer, Juliano Augusto Brum, et al.
Publicado: (2018)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle
por: Liu, Xin, et al.
Publicado: (2022)

The effect of early coasting on blastocyst development and outcome following blastocyst transfer in IVF/ICSI programme
por: Kailasam, Chandra, et al.
Publicado: (2018)

Anti-Müllerian hormone and progesterone levels produced by granulosa cells are higher when derived from natural cycle IVF than from conventional gonadotropin-stimulated IVF
por: Kollmann, Zahraa, et al.
Publicado: (2015)

Investigation of anti-mullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles
por: Safdarian, Leili, et al.
Publicado: (2018)

Does dysbiotic endometrium affect blastocyst implantation in IVF patients?
por: Hashimoto, Tomoko, et al.
Publicado: (2019)

Non-invasive preimplantation genetic testing for conventional IVF blastocysts
por: Xie, Pingyuan, et al.
Publicado: (2022)

Anti-mullerian hormone as a predictor of ovarian reserve and ovarian response in IVF women from Gaza strip
por: Mohammed Yassin, Maged, et al.
Publicado: (2013)

Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment
por: Zhao, Depeng, et al.
Publicado: (2021)

High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment
por: Sun, Tie-Cheng, et al.
Publicado: (2021)

Pre-treatment preferences and characteristics among patients seeking in vitro fertilisation
por: Walsh, Anthony PH, et al.
Publicado: (2009)

Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis
por: Yoo, Ji Hee, et al.
Publicado: (2011)

Irish public opinion on assisted human reproduction services: Contemporary assessments from a national sample
por: Walsh, David J, et al.
Publicado: (2013)

Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values
por: Schenk, Michael, et al.
Publicado: (2017)

Normalized Ploidy Following 20 Consecutive Blastocysts with Chromosomal Error: Healthy 46, XY Pregnancy with IVF after Intraovarian Injection of Autologous Enriched Platelet-derived Growth Factors
por: Sills, E. Scott, et al.
Publicado: (2019)

Selection of euploid blastocysts for cryopreservation with array comparative genomic hybridization (aCGH) results in increased implantation rates in subsequent frozen and thawed embryo transfer cycles
por: Yang, Zhihong, et al.
Publicado: (2013)

Sequential cleavage and blastocyst embryo transfer and IVF outcomes: a systematic review
por: Zhang, Jianeng, et al.
Publicado: (2021)

How general semen quality influences the blastocyst formation rate: Analysis of 4205 IVF cycles
por: Piccolomini, Mariana M, et al.
Publicado: (2018)

Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study
por: Zheng, Haiyan, et al.
Publicado: (2017)

Serum anti-Müllerian hormone levels are associated with perinatal outcomes in women undergoing IVF/ICSI: A multicenter retrospective cohort study
por: He, Yi-Chen, et al.
Publicado: (2023)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytes
por: Yang, Zhihong, et al.
Publicado: (2014)

Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
por: Wang, Shunping, et al.
Publicado: (2018)

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)

Clinical Utilities of Anti-Müllerian Hormone
por: Russell, Nicole, et al.
Publicado: (2022)

The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age
por: Lee, Robert KK, et al.
Publicado: (2011)

Follicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles
por: Mehta, Bindu N, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_489mklj74n32qh7ec57hfo7fdq